1. Chen, Jiayin, Wang, Li, Tong, Gangling, Liu, Chaoran, Wang, Lijun. . The SLC22A2 gene is a determinant of hematological toxicity of oxaliplatin in patients with colorectal cancer. In International journal of clinical pharmacology and therapeutics, 61, 1-7. doi:10.5414/CP204156. https://pubmed.ncbi.nlm.nih.gov/36331012/
2. Abrahams-October, Zainonesa, Lloyd, Sheridon, Pearce, Brendon, Johnson, Rabia, Benjeddou, Mongi. 2022. Promoter haplotype structure of solute carrier 22 member 2 (SLC22A2) in the Xhosa population of South Africa and their differential effect on gene expression. In Gene, 820, 146292. doi:10.1016/j.gene.2022.146292. https://pubmed.ncbi.nlm.nih.gov/35143948/
3. Li, Qing, Liu, Fang, Zheng, Tai-shan, Lu, Hui-juan, Jia, Wei-ping. . SLC22A2 gene 808 G/T variant is related to plasma lactate concentration in Chinese type 2 diabetics treated with metformin. In Acta pharmacologica Sinica, 31, 184-90. doi:10.1038/aps.2009.189. https://pubmed.ncbi.nlm.nih.gov/20139901/
4. Pearce, Brendon, Jacobs, Clifford, Hoosain, Nisreen, Benjeddou, Mongi. . SLC22A2 - mapping genomic variations within South African indigenous and admixed populations. In Drug metabolism and personalized therapy, 31, 213-220. doi:10.1515/dmpt-2016-0022. https://pubmed.ncbi.nlm.nih.gov/27828777/
5. Borghetti, A, Calcagno, A, Lombardi, F, Bonora, S, Di Giambenedetto, S. . SLC22A2 variants and dolutegravir levels correlate with psychiatric symptoms in persons with HIV. In The Journal of antimicrobial chemotherapy, 74, 1035-1043. doi:10.1093/jac/dky508. https://pubmed.ncbi.nlm.nih.gov/30561642/
智鼠故事 
